Eli Lilly: New $1 Trillion Giant! Weight Loss Drugs Propel the Pharma Heavyweight to new Heights!
Reading Time: 3 minutes
Fear is spreading across the US stock markets. The Fear & Greed Index recently dropped below 10, reaching a level similar to early April after the announcement of tariff increases by Donald Trump. In such times, I act counter-cyclically and invest in strong companies. Currently, the "Healthcare" sector is leading, with Eli Lilly standing out with an increase of over 28% in the "Drug Manufacturers – General" category. What exactly is going well? Eli Lilly develops medications in various disease fields Mounjaro and Zepbound are currently...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
